Role of the immune receptor Nod1 in inflammation-associated colon tumorigenesis

免疫受体Nod1在炎症相关结肠肿瘤发生中的作用

基本信息

  • 批准号:
    7588189
  • 负责人:
  • 金额:
    $ 13.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-16 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Patients with inflammatory bowel disease have a substantially increased risk of developing colon cancer. The events that lead from chronic colitis to colon carcinogenesis are not fully understood, but are likely related to an abnormal immune response to the gut microflora and subsequent production of reactive oxygen species, pro-inflammatory cytokines, anti-apoptotic factors, and angiogenic promoting signals during the inflammatory response, that are all conducive to tumorigenesis. The goal of this proposal is to investigate the role of the immune receptor Nod1 in inflammation-associated colon tumorigenesis using a mouse model that involves a single injection of a carcinogen followed by multiple rounds of water containing dextran sulfate sodium (DSS), which causes colitis. Nod1 is a component of the innate immune system that recognizes peptidoglycan moieties found in bacteria, including those of the gut microbiota. Preliminary data suggest that Nod1 signaling by the gut microbiota protects against the development of colon tumors in the setting of chronic inflammation. The mechanism behind this protective effect is unknown, but our data suggest that an interaction between the Nod1 receptor and the gut microbiota is important for maintenance of intestinal homeostasis and tumor suppression. Nod1 knockout mice, compared to wildtype, also have increased basal levels of the adipocytokine, adiponectin, an inflammatory mediator derived primarily from adipose tissue that has also been shown to be important in the development of chemically-induced colitis. Thus, the specific aims of this proposal are: 1) to elucidate the mechanism by which Nod1 signaling protects against colon tumor initiation and progression, 2) to examine the role of the adipocytokine, adiponectin, in the susceptibility of Nod1 knockout mice to tumor formation during chronic inflammation, and 3) to determine the importance of the intestinal microflora in Nod1-mediated tumor suppression. The proposed experiments will provide a deeper understanding of how interactions between the gut microbiota and the innate immune system strongly influence the development of colonic inflammation and subsequent tumorigenesis. In addition, the proposed research will help lay a foundation in the development of a clinical strategy that involves the manipulation of Nod1 signaling to prevent inflammation-associated colon cancer in humans.
描述(由申请人提供):炎症性肠病患者发生结肠癌的风险显著增加。从慢性结肠炎到结肠癌发生的事件尚不完全清楚,但可能与对肠道微生物菌群的异常免疫反应以及随后在炎症反应期间产生活性氧、促炎细胞因子、抗凋亡因子和血管生成促进信号有关,这些都有助于肿瘤发生。该提案的目标是使用小鼠模型研究免疫受体Nod1在炎症相关结肠肿瘤发生中的作用,该模型涉及单次注射致癌物质,然后多轮含有葡聚糖硫酸钠(DSS)的水,这会导致结肠炎。Nod1是先天免疫系统的一个组成部分,识别细菌中发现的肽聚糖部分,包括肠道微生物群的肽聚糖部分。初步数据表明,肠道微生物群的Nod1信号传导可以防止慢性炎症环境中结肠肿瘤的发展。这种保护作用背后的机制尚不清楚,但我们的数据表明,Nod1受体和肠道微生物群之间的相互作用对于维持肠道稳态和肿瘤抑制非常重要。与野生型相比,Nod1基因敲除小鼠的脂肪细胞因子脂联素的基础水平也有所增加,脂联素是一种主要来源于脂肪组织的炎症介质,在化学诱导的结肠炎的发展中也很重要。因此,本提案的具体目的是:1)阐明Nod1信号传导保护结肠肿瘤起始和进展的机制,2)检查脂肪细胞因子脂联素在Nod1敲除小鼠对慢性炎症期间肿瘤形成的易感性中的作用,以及3)确定肠道微生物群落在Nod1介导的肿瘤抑制中的重要性。拟议的实验将更深入地了解肠道微生物群和先天免疫系统之间的相互作用如何强烈影响结肠炎症的发展和随后的肿瘤发生。此外,拟议的研究将有助于为开发一种临床策略奠定基础,该策略涉及操纵Nod1信号传导以预防人类炎症相关结肠癌。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GRACE Y. CHEN其他文献

GRACE Y. CHEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GRACE Y. CHEN', 18)}}的其他基金

Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention
针对癌症干细胞样细胞和炎症进行结肠癌化学预防
  • 批准号:
    10650910
  • 财政年份:
    2023
  • 资助金额:
    $ 13.31万
  • 项目类别:
Understanding NLRP6 function in intestinal homeostasis
了解 NLRP6 在肠道稳态中的功能
  • 批准号:
    10393573
  • 财政年份:
    2019
  • 资助金额:
    $ 13.31万
  • 项目类别:
Dietary fiber and soy protein-based microbiome metabolites for IBD prevention
基于膳食纤维和大豆蛋白的微生物组代谢物用于预防 IBD
  • 批准号:
    10607658
  • 财政年份:
    2018
  • 资助金额:
    $ 13.31万
  • 项目类别:
(10.) The Gut Microbiome and Responses to Neoadjuvant Chemoradiation in Rectal Cancer Patients
(10.) 直肠癌患者的肠道微生物群和对新辅助放化疗的反应
  • 批准号:
    9250105
  • 财政年份:
    2016
  • 资助金额:
    $ 13.31万
  • 项目类别:
(10.) The Gut Microbiome and Responses to Neoadjuvant Chemoradiation in Rectal Cancer Patients
(10.) 直肠癌患者的肠道微生物群和对新辅助放化疗的反应
  • 批准号:
    9100263
  • 财政年份:
    2016
  • 资助金额:
    $ 13.31万
  • 项目类别:
Identifying bacterial regulators of tumorigenesis
识别肿瘤发生的细菌调节因子
  • 批准号:
    8982222
  • 财政年份:
    2014
  • 资助金额:
    $ 13.31万
  • 项目类别:
Identifying bacterial regulators of tumorigenesis
识别肿瘤发生的细菌调节因子
  • 批准号:
    8814012
  • 财政年份:
    2014
  • 资助金额:
    $ 13.31万
  • 项目类别:
Regulation of intestinal inflammation and tumorigenesis by Nlrp6
Nlrp6 对肠道炎症和肿瘤发生的调节
  • 批准号:
    8606443
  • 财政年份:
    2013
  • 资助金额:
    $ 13.31万
  • 项目类别:
Regulation of intestinal inflammation and tumorigenesis by Nlrp6
Nlrp6 对肠道炎症和肿瘤发生的调节
  • 批准号:
    8436792
  • 财政年份:
    2013
  • 资助金额:
    $ 13.31万
  • 项目类别:
Role of the immune receptor Nod1 in inflammation-associated colon tumorigenesis
免疫受体Nod1在炎症相关结肠肿瘤发生中的作用
  • 批准号:
    7912863
  • 财政年份:
    2008
  • 资助金额:
    $ 13.31万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 13.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 13.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 13.31万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 13.31万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 13.31万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 13.31万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 13.31万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 13.31万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 13.31万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 13.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了